📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Calistoga Pharmaceuticals

1.1 - Company Overview

Calistoga Pharmaceuticals Logo

Calistoga Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapeutic oral medicines targeting selected isoforms of the PI3K pathway to improve the health of patients with cancer and inflammatory diseases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Calistoga Pharmaceuticals

Mythic Therapeutics Logo

Mythic Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology-based cancer therapeutics, including MYTX-011, an investigational cMET-targeting antibody-drug conjugate designed to increase delivery of chemotherapy to cancer cells while reducing uptake in healthy cells; FateControl™, a platform that enhances ADC uptake in cancer cells and minimizes payload release in normal cells to improve potency and tolerability; and KisMET-01, a Phase 1 trial in NSCLC.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mythic Therapeutics company profile →
Xstrahl Logo

Xstrahl

HQ: United States Website
  • Description: Provider of superficial orthovoltage X-ray systems for treating skin and bone cancers, dermatological disorders, benign conditions, and for palliative care, with precise non-surgical options. Also offers a compact office-based dual-modality device for non-melanoma skin cancers and keloid scarring, and advanced X-ray platforms for preclinical radiation biology research.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Xstrahl company profile →
Allorion Therapeutics Logo

Allorion Therapeutics

HQ: United States Website
  • Description: Provider of small-molecule therapeutics for cancer and autoimmune diseases, including an EGFR L858R allosteric inhibitor program to enhance existing treatments and prevent resistance; ARTS-021, an oral CDK2 inhibitor in Phase I/II for advanced/metastatic solid tumors; ARTS-011, a selective TYK2 inhibitor in early development; and high-throughput phenotypic screening to identify Werner Helicase inhibitors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Allorion Therapeutics company profile →
Tilt Biotherapeutics Logo

Tilt Biotherapeutics

HQ: Finland Website
  • Description: Provider of oncolytic viral cancer immunotherapies that enable tumor T-cell therapy by modifying the tumor microenvironment. Pipeline includes TILT-123 (cytokine-armed oncolytic adenovirus, in Phase 1), TILT-234 (Ad3 armed with human CD40L, ready for CMC/regulatory), TILT-321/322 (bispecific antibody-coding adenoviruses, discovery), and TILT-452 (preclinical), with clinical trial collaborations on TILT-123 with Merck KGaA and MSD.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tilt Biotherapeutics company profile →
Bolt Biotherapeutics Logo

Bolt Biotherapeutics

HQ: United States Website
  • Description: Provider of a biotechnology platform for cancer immunotherapy.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bolt Biotherapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Calistoga Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Calistoga Pharmaceuticals

2.2 - Growth funds investing in similar companies to Calistoga Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Calistoga Pharmaceuticals

4.2 - Public trading comparable groups for Calistoga Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Calistoga Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Calistoga Pharmaceuticals

What does Calistoga Pharmaceuticals do?

Calistoga Pharmaceuticals is a provider of therapeutic oral medicines targeting selected isoforms of the PI3K pathway to improve the health of patients with cancer and inflammatory diseases.

Who are Calistoga Pharmaceuticals's competitors?

Calistoga Pharmaceuticals's competitors and similar companies include Mythic Therapeutics, Xstrahl, Allorion Therapeutics, Tilt Biotherapeutics, and Bolt Biotherapeutics.

Where is Calistoga Pharmaceuticals headquartered?

Calistoga Pharmaceuticals is headquartered in United States.

How many employees does Calistoga Pharmaceuticals have?

Calistoga Pharmaceuticals has 1,000 employees 🔒.

When was Calistoga Pharmaceuticals founded?

Calistoga Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Calistoga Pharmaceuticals in?

Calistoga Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Calistoga Pharmaceuticals

Who are the top strategic acquirers in Calistoga Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Calistoga Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Calistoga Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Calistoga Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Calistoga Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Calistoga Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Calistoga Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Calistoga Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Calistoga Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Calistoga Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Calistoga Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Calistoga Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Calistoga Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Calistoga Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Calistoga Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Calistoga Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Calistoga Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Calistoga Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Calistoga Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Calistoga Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Calistoga Pharmaceuticals